2X3-26043-37609
3 vaccinations
2 coded responses
8 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 945 / CA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-26
- 2020-12-27
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Eye pain, Fatigue, Myalgia, Pyrexia, Therapeutic response unexpected — Feeling: Good · Site: Redness, SwellingFree text: I had muscle aches, eye pain, joint pain, fatigue and fever less than 24 hrs after injection- resolved by 50 hrs afterMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-27
-
2021-09-18
Dose 3 — Pfizer-BioNTech
- 2021-09-28
-
2022-09-18
Survey response — 12 months, dose 3MedDRA: Asthma, COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Asthma COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-09-18
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-09-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-09-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-18 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): I had muscle aches, eye pain, joint pain, fatigue and fever less than 24 hrs after injection- resolved by 50 hrs after
Release 12 — 12 months, dose 3
Symptoms: Asthma COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Therapeutic response unexpected | ✓ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release